Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of Perrigo's product to an
FDA approved product for the treatment of inflammatory lesions rosacea